Cryosite Limited (AU:CTE) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Cryosite Limited has reported robust performance and strong cash flow, with plans to expand storage capacity and delve into biological storage and cell & gene therapy services. The company has also appointed Scott Thomas, who brings extensive financial experience, as a new Director. Shareholders are informed that Cryosite aims to pay further dividends in the current year following a successful audit of FY24 financials.
For further insights into AU:CTE stock, check out TipRanks’ Stock Analysis page.